CorMedix Stock Discussion

I’ve been swing trading ‘em for a while; went long, months ago… singular product (DefenCath) of great importance, transitioned from R&D to production/sales. Simple.
Until it wasn’t… Joe Todisco’s leadership, as CEO, troubles me.
CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE - CorMedix | Prevention of cardiac, renal and infectious diseases
$72-78mm spending in 2025, “…largely driven by R&D,” they said?
“[Co...